By targeting two pathways instead of one, Tirzepatide creates a powerful synergistic effect that leads to significant weight loss and major metabolic improvements

Skip to main content About About SGC Members & Technology Partners Governance Open Science Impact SGC Gender Equality Plan SGC Sites & People Global SGC Toronto SGC UNC SGC Karolinska SGC Frankfurt SGC Neuro SGC UCL SGC Unicamp Science and Resources Proteins Structure Gallery Protein Production Resources Expression Vectors Constructs Legacy Protein Protocols Chemistry Chemical Probes SGC Chemical Probes Donated Chemical Probes Chemical Handles Chemogenomic Sets Open Data Target Enabling Packages Patient Tissue Platform Open Lab Notebooks Publications Bioinformatics Resources ChemBioPort UbiHub ChromoHub Initiatives Overview Target 2035 Protein Contribution Network AIRCHECK MAINFRAME CACHE Conscience Agora Open Science Trust EUbOPEN Open Chemistry Networks Womens and Childrens Health Initiative READDI AViDD TREAT AD YCharOS News & Outreach News from SGC Press Releases Blogs Get Involved Participate Donate Careers Contact Us Donate Home About About SGC Members & Technology Partners Governance Open Science Impact SGC Gender Equality Plan SGC Sites & People Global SGC Toronto SGC UNC SGC Karolinska SGC Frankfurt SGC Neuro SGC UCL SGC Unicamp Science and Resources Proteins Structure Gallery Protein Production Resources Expression Vectors Constructs Legacy Protein Protocols Chemistry Chemical Probes SGC Chemical Probes Donated Chemical Probes Chemical Handles Chemogenomic Sets Open Data Target Enabling Packages Patient Tissue Platform Open Lab Notebooks Publications Bioinformatics Resources ChemBioPort UbiHub ChromoHub Initiatives Overview Target 2035 Protein Contribution Network AIRCHECK MAINFRAME CACHE Conscience Agora Open Science Trust EUbOPEN Open Chemistry Networks Womens and Childrens Health Initiative READDI AViDD TREAT AD YCharOS News & Outreach News from SGC Press Releases Blogs Get Involved Participate Donate Careers Contact Us Donate Search Crystal structure of human glutathione peroxidase 5 Protein: GPX5 PDB ID: 2I3Y Deposition Date: Monday 21st August 2006 Authors: Kavanagh, K.L., Johansson, C., Rojkova, A., Umeano, C., Bunkoczi, G., Gileadi, O., von Delft, F., Weigelt, J., Arrowsmith, C., Sundstrom, M., Edwards, A., Oppermann, U.

Adults using an SGLT2 inhibitor had a lower risk for CKD progression compared with those receiving placebo (HR = 0.67
Weight loss of this magnitude is transformative for cardiovascular risk
Cao Q, Shen M, Li R, Liu Y, Zeng Z, Zhou J, et al